Showing results (1071-1080 of 19,546) with videos related to
Sort By:
Pageof 1,955
BMC Cancer|January 9, 2019
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II studyYoshihiko Tomita, Hirotsugu Uemura, Mototsugu Oya, et al.BMC Cancer|January 9, 2019
A modified subclassification to evaluate the survival of patients with N3 gastric cancer: an international database studyMan-Qiang Lin, Jia-Bin Wang, Chao-Hui Zheng, et al.BMC Cancer|January 9, 2019
Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]Jeremie Calais, Johannes Czernin, Wolfgang P Fendler, et al.BMC Cancer|January 10, 2019
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancerHakon Blomstrand, Ursula Scheibling, Charlotte Bratthäll, et al.BMC Cancer|January 10, 2019
Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic areaJi-Jin Yao, Feng-Ting Zhu, Jun Dong, et al.BMC Cancer|January 10, 2019
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cellsXiaofu Qiu, Wei Wang, Bijun Li, et al.BMC Cancer|January 10, 2019
miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBαHe Xin, Chuanzhuo Wang, Zhaoyu LiuBMC Cancer|January 11, 2019
Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysisQing An, Zhihao LiuBMC Cancer|January 11, 2019
Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT studyA K Lofters, M L McBride, D Li, et al.BMC Cancer|January 12, 2019
Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapyPornprom Ittiamornlert, Irene RuengkhachornPageof 1,955